Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
Open Access
- 7 November 2011
- journal article
- review article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 66 (3), 479-485
- https://doi.org/10.1016/j.jaad.2011.06.032
Abstract
Our scientific knowledge of bullous pemphigoid (BP) has dramatically progressed in recent years. However, despite the availability of various therapeutic options for the treatment of inflammatory diseases, only a few multicenter controlled trials have helped to define effective therapies in BP. A major obstacle in sharing multicenter-based evidences for therapeutic efforts is the lack of generally accepted definitions for the clinical evaluation of patients with BP. Common terms and end points of BP are needed so that experts in the field can accurately measure and assess disease extent, activity, severity, and therapeutic response, and thus facilitate and advance clinical trials. These recommendations from the International Pemphigoid Committee represent 2 years of collaborative efforts to attain mutually acceptable common definitions for BP and proposes a disease extent score, the BP Disease Area Index. These items should assist in the development of consistent reporting of outcomes in future BP reports and studies.Keywords
This publication has 11 references indexed in Scilit:
- Interventions for bullous pemphigoidCochrane Database of Systematic Reviews, 2010
- A Pilot Study of Etanercept Treatment for Pemphigus VulgarisArchives of Dermatology, 2010
- Reliability and Convergent Validity of Two Outcome Instruments for PemphigusJournal of Investigative Dermatology, 2009
- A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients with Bullous Pemphigoid: A Multicenter Randomized StudyJournal of Investigative Dermatology, 2009
- Consensus statement on definitions of disease, end points, and therapeutic response for pemphigusJournal of the American Academy of Dermatology, 2008
- Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus.Published by PERSEE Program ,2007
- A Comparison of Oral and Topical Corticosteroids in Patients with Bullous PemphigoidNew England Journal of Medicine, 2002
- Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group.1995
- Incidence and Distribution of Subepidermal Autoimmune Bullous Skin Diseases in Three French RegionsArchives of Dermatology, 1995
- TREATMENT OF BULLOUS PEMPHIGOID WITH PREDNISOLONE ONLY - 0.75 MG-KG-DAY - RESULTS OF A RANDOMIZED PLURICENTRIC STUDY1984